ATHE Alterity Therapeutics Limited
$4.05▼ -1.46%
Healthcare
Other
After hours
$4.05▲ +0.00%
Sep 11, 7:30 PM ET
Volume 22.3K
Avg Volume (10D) 17.4K
Key Metrics & Fundamentals
Market Cap
$73.74M
P/E Ratio
–
Div Yield
–%
52W Range
2.66 - 5.89
% vs 50 MA
-13.61%
% vs 200 MA
2.39%
RSI-14
36.1
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.34
Free Cash Flow
-$7.17M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
GlobeNewswire · Sep 3, 2026 11:05 AM
Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
GlobeNewswire · Aug 12, 2026 11:05 AM
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
GlobeNewswire · Aug 6, 2026 11:25 AM
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
GlobeNewswire · Jul 30, 2026 11:25 AM
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
GlobeNewswire · Jul 21, 2026 11:25 AM
Alterity Therapeutics Says FDA Backs Phase 3 Design for Multiple System Atrophy Therapy
MT Newswires · Jul 7, 2026 11:45 AM
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy
GlobeNewswire · Jul 7, 2026 11:05 AM
Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?
Zacks · Jun 19, 2026 1:40 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ATHE's money flow as a full page
Social Sentiment
No Reddit posts found for ATHE.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.